Physician profile
Eric S Hansen
NPI 1306823364
$1,044.86
in general payments reported to CMS, 2019-2025
13 companies · $34.02 in 2025
The $34.02 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $108 · 2021: $158 · 2022: $15.04 · 2023: $98.93 · 2024: $46.08 · 2025: $34.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $380.94 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $171.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $129.06 | 2019 | |
| Allergan, INC. | $116.50 | 2019-2020 | |
| Abbvie INC. | $110.28 | 2021-2023 | |
| Exact Sciences Corporation | $33.50 | 2023-2024 | Cologuard Collection Kit |
| Radius Health, INC. | $18.51 | 2025 | Tymlos |
| Janssen Biotech, INC. | $18.26 | 2024 | Tremfya |
| Smith+Nephew, INC. | $13.89 | 2024 | Regranex, Collagenase Santyl |
| Merck Sharp & Dohme LLC | $13.77 | 2019 | |
| Amarin Pharma, INC. | $13.40 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.81 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.